switching from insulin to glp-1 Frontiers Clinical Focus on GLP-1 Agonists

For researchers building a comprehensive IGF axis research workflow, the standard approach is to use IGF-1 LR3 as the primary tool for sustained IGF1R activation studies, native IGF-1 for short-pulse studies where IGFBP biology is itself the research question, and DES IGF-1 for the narrow set of experiments requiring receptor activation with rapid washout

For those dealing with immune challenges or seeking to optimize immune function, this product provides oral access to a peptide with substantial clinical backing

when GSH is taken orally, it has low bioavailability and is easily broken down by the stomach and is not effective

A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers